HSPB1 and cancer: A number of molecules, including RP101 (Brivudine) and Quercetin, and OGX-427 have yielded promising results in vitro, in vivo as well as in early-stage clinical trials, thus not only confirming the key role of Hsp27 in cancer’s chemotherapy resistance but also indicating a novel therapeutic approach.